Cite
Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms
MLA
Mercedes Berenguer, et al. “Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms.” International Journal of Molecular Sciences, vol. 22, no. 3895, Apr. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06287b91d4d5e06b7b40e2ee0901c8ea&authtype=sso&custid=ns315887.
APA
Mercedes Berenguer, José A. Campillo, Valentin Cabañas, Adela Periago, María F Soto-Ramírez, Alfredo Minguela, Lourdes Gimeno, María C García-Garay, Manuel Muro, María D. Martínez-Hernández, & María A Vasco-Mogorrón. (2021). Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms. International Journal of Molecular Sciences, 22(3895).
Chicago
Mercedes Berenguer, José A. Campillo, Valentin Cabañas, Adela Periago, María F Soto-Ramírez, Alfredo Minguela, Lourdes Gimeno, et al. 2021. “Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms.” International Journal of Molecular Sciences 22 (3895). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....06287b91d4d5e06b7b40e2ee0901c8ea&authtype=sso&custid=ns315887.